-
Li & Fung, in US$100 million strategic investment by JD.com.
-
GLP Pte. Ltd. and the consortium offeror comprising the Fung family and GLP, in its proposed privatization of Li & Fung, a company listed on the Hong Kong Stock Exchange (HKSE: 494).
-
Advising Malaysian sovereign fund in its investment in the US$14 billion Series C equity financing of Ant Financial.
-
Advising a consortium comprising FountainVest Partners and Ontario Teachers’ Pension Plan on its investment partnership with the Pure Group, Asia’s leading premium lifestyle brand that includes Pure Yoga, Pure Fitness, Pure Apparel and nood food.
-
Advising Midea International Corporation Company Limited, a wholly-owned subsidiary of Midea Group Co., Ltd. (000333.SZ), in its proposed privatisation of Welling Holding Limited (HKSE: 382).
-
A consortium comprising Hillhouse Capital Management, HOPU Investment Management, Global Logistic Properties Limited (GLP) founder Ming Mei’s SMG, Bank of China Group Investment and China Vanke Co. or their affiliated entities in its US$11.6 billion acquisition of GLP (SGX: MC0). GLP is Asia’s leading warehouse operator with a multibillion-dollar portfolio of assets spread across China, Japan, Brazil and the United States. The transaction is the largest private equity-backed takeover in Asia (ex-Japan) to date. This transaction was named Deal of the Year and Best Leveraged Finance Deal by FinanceAsia Achievement Awards 2017 and M&A Deal of the Year: Southeast Asia by The Asia Legal Awards 2018.
-
Advising Hillhouse Capital Group and CareCapital Advisors Limited in its acquisition of a minority stake in a newly-formed company that will acquire Carestream’s dental digital business from Onex Corporation in partnership with Clayton, Dubilier & Rice.
-
Advising The Carlyle Group, CITIC Limited and CITIC Capital Holdings in the US$2.08 billion acquisition of the McDonald’s operations in China and Hong Kong and negotiation of a 20-year master franchise agreement ― the largest McDonald’s franchise in the world.
-
A Hong Kong listed company on the sale of its major asset which constituted a very substantial disposal under the Hong Kong Listing Rules
-
A Malaysian listed company on its sale of certain of its businesses in South-East Asia and Hong Kong to an Australian listed company
-
A PRC retail and media company on its proposed outbound investment in certain European entities
-
A PRC investment consortium on its proposed outbound investment in certain European entities
-
A PRC pharmaceuticals company on its proposed sale of certain of its businesses to a listed company
-
A Singaporean listed company on its acquisition of interests in entities operating aged care facilities and ultimately controlled by an Australian listed company
-
An Australian listed company on its acquisition of a major Australia consumer food products group from another Australian listed company
-
An Australian food and agricultural company on its acquisition by an Australian listed company
-
An Australian transport company on the sale of its defence contracting business to a US-listed company
-
An Australian transport company on the sale of its parcel delivery joint venture interest
-
An Australian transport company on the sale of certain catering operations to a European company
-
An Australian listed company on the sale of its mortgage services related business to a private Australian financing company
-
A UK listed company on its acquisition of an Australian communications services company
-
A major Australia professional organization on its merger with its regional counterpart
-
An Australian property developer on its joint venture with a Malaysian property investment company
-
A global investment bank as the sponsor and underwriter of the Hong Kong initial public offering and global offering of a consumer garments company
-
A company in the healthcare industry on its Hong Kong initial public offering and global offering
-
3 global and regional investment banks as placing agents on a share sale by a Hong Kong listed company to its ultimate parent and other investors to finance the proposed acquisition of a pharmaceuticals company in China
-
A global investment bank as the placing agent in the share offering of a Hong Kong listed company
-
A Hong Kong listed company in its capital reorganizations and rights issues in 2015 and 2016
-
2 separate Hong Kong listed companies on their rights issues in 2015
